Allogeneic stem cell transplantation for sickle cell disease.

about

Treating sickle cell disease by targeting HbS polymerization Developing new pharmacotherapeutic approaches to treating sickle-cell disease.

P2860

Q33707352-43CB1601-2C5A-4912-8846-02E2B218A84C Q50207951-11AA0349-1878-4E1F-9997-D52FA4F5909B

P2860

Allogeneic stem cell transplantation for sickle cell disease.

Item

http://www.wikidata.org/entity/Q38920191

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Allogeneic stem cell transplantation for sickle cell disease.

@en

type

Item

label

Allogeneic stem cell transplantation for sickle cell disease.

@en

prefLabel

Allogeneic stem cell transplantation for sickle cell disease.

@en

P1476

Allogeneic stem cell transplantation for sickle cell disease.

@en

P2093

Ephraim J Fuchs

http://www.w3.org/2001/XMLSchema#string

Tara M Robinson

http://www.w3.org/2001/XMLSchema#string

P2860

Pulmonary, gonadal, and central nervous system status after bone marrow transplantation for sickle cell disease

Immunologic effects of hydroxyurea in sickle cell anemia.

Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide.

One-antigen mismatched related versus HLA-matched unrelated donor hematopoietic stem cell transplantation in adults with acute leukemia: Center for International Blood and Marrow Transplant Research results in the era of molecular HLA typing.

Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype.

HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease.

Long-term outcome and evaluation of organ function in pediatric patients undergoing haploidentical and matched related hematopoietic cell transplantation for sickle cell disease.

Mortality rates and age at death from sickle cell disease: U.S., 1979-2005.

Disability among individuals with sickle cell disease: literature review from a public health perspective.

P304

524-529

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MOH.0000000000000282

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-08-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27496639

http://www.w3.org/2001/XMLSchema#string

P921

sickle-cell disease

P932

5130409

http://www.w3.org/2001/XMLSchema#string

Allogeneic stem cell transplantation for sickle cell disease.

about

P2860

P2860

Allogeneic stem cell transplantation for sickle cell disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932